Pharmicell Co., Ltd. (KRX:005690)
South Korea
· Delayed Price · Currency is KRW 16,920
-140 (-0.82%)
Last updated: Dec 5, 2025, 10:16 AM KST
Pharmicell Revenue
Pharmicell had revenue of 3.65B KRW in the quarter ending June 30, 2014, a decrease of -58.16%. This brings the company's revenue in the last twelve months to 23.94B, down -3.60% year-over-year. In the year 2013, Pharmicell had annual revenue of 33.41B with 200.63% growth.
Revenue (ttm)
23.94B
Revenue Growth
-3.60%
P/S Ratio
43.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
1,031.47B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |